Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 25.30B P/E 3.70 EPS this Y -150.70% Ern Qtrly Grth -79.90%
Income 930.3M Forward P/E 26.58 EPS next Y 30.00% 50D Avg Chg -3.00%
Sales 3.82B PEG 1.19 EPS past 5Y -35.56% 200D Avg Chg -20.00%
Dividend N/A Price/Book 1.25 EPS next 5Y -33.67% 52W High Chg -44.00%
Recommedations 2.50 Quick Ratio 9.12 Shares Outstanding 240.99M 52W Low Chg 5.00%
Insider Own 62.84% ROA 2.62% Shares Float 88.96M Beta 0.23
Inst Own 18.34% ROE 4.62% Shares Shorted/Prior 3.08M/2.92M Price 104.98
Gross Margin 84.29% Profit Margin 24.36% Avg. Volume 689,574 Target Price 118.25
Oper. Margin 40.00% Earnings Date May 6 Volume 591,875 Change -2.01%
About BioNTech SE

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV 16+ head and neck cancers; BNT114 to treat triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, which is in Phase I clinical trial for non-small cell lung cancer. It develops BNT122, which is in Phase II clinical trial for first-line melanoma and in Phase I clinical trial to treat multiple solid tumors; BNT131 that is in Phase I clinical trial for multiple solid tumors; BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors; BNT151, BNT152, and BNT153 to treat solid tumors; BNT211 to treat multiple solid tumors, and BNT221 for pancreatic and other cancers; BNT311 which are in Phase II clinical trial to treat metastatic non-small cell lung cancer and Phase I/II clinical trial to treat multiple solid tumors; and BNT312, which is in Phase 2 clinical trial to treat multiple solid tumors, as well as ONC-392, which is in Phase III clinical trial to treat ovarian cancer and Phase I/II clinical trial to treat multiple solid tumors. It develops BNT321, an IgG1 monoclonal antibody in Phase I clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate in Phase I clinical trial for solid tumors; BNT322, which is in Phase I/Ib clinical trial for multiple solid tumors; and prophylactic vaccine for shingles, malaria, tuberculosis, HSV-2, and other infectious diseases. It has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd; and Ryvu Therapeutics S.A. BioNTech SE was incorporated in 2008 and is based in Mainz, Germany.

BioNTech SE News
04/23/24 Pfizer vs Moderna battle over COVID vaccine patents begins in UK
04/22/24 25 Richest Billionaires in Healthcare Industry
04/22/24 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
04/07/24 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer
03/31/24 The 3 Best Bargain Stocks to Buy in Q2 2024
03/26/24 3 Biotech Stocks to Buy for the Next Bull Run: March 2024
03/26/24 This Vaccine Maker Sits on Cash Almost Equal to Its Market Value
03/25/24 UPDATE 2-BioNTech gets US agency notice over default on COVID vaccine royalties
07:59 AM BioNTech Full Year 2023 Earnings: Misses Expectations
03/23/24 Earnings Miss: BioNTech SE Missed EPS By 14% And Analysts Are Revising Their Forecasts
03/21/24 BioNTech SE (NASDAQ:BNTX) Q4 2023 Earnings Call Transcript
03/21/24 Q4 2023 BioNTech SE Earnings Call
03/20/24 BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts
03/20/24 BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials
03/20/24 BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript
03/20/24 BioNTech expects more than 10 bln eur peak sales from cancer drug pipeline
03/20/24 BioNTech Earnings Miss Estimates. The Stock Falls and Also Drags Moderna Lower.
03/20/24 UPDATE 1-After earnings plunge, BioNTech pins hopes on cancer drug launches
03/20/24 BioNTech slides as earnings plunge amid cancer drug shift
03/20/24 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
BNTX Chatroom

User Image distanceswimmer Posted - 22 minutes ago

$BNTX $MRNA $PFE

User Image taxplanr Posted - 9 hours ago

$BNTX $MRNA $PFE I got forwarded this from facebook about a new "Premier League" foosball edition https://www.facebook.com/story.php?story_fbid=988092816008416&id=100044231209490&mibextid=WC7FNe&rdid=s3FBYcRXuPrSaQkJ

User Image taxplanr Posted - 13 hours ago

$MRNA $BNTX $PFE

User Image taxplanr Posted - 13 hours ago

If I was a shareholder I would want to know $PFE $MRNA $BNTX https://x.com/AndersonAfDMdEP/status/1782639942746652930

User Image taxplanr Posted - 1 day ago

$MRNA $PFE $BNTX you have been told

User Image Skynet2020 Posted - 1 day ago

$BNTX My whole stock is green….except this garbage.

User Image WhisperNumber Posted - 1 day ago

$BIIB #earnings before open Wed, the expectation from the WhisperNumber community is $3.56, 12c ahead of analyst estimates. Earnings came in $0.35 short of the whisper last quarter. 61% beat rate. Implied movement +/-5.5%. https://www.whispernumber.com/wr_options_alerts.jsp #options $ARGX $BNTX

User Image Skynet2020 Posted - 1 day ago

$BNTX So dissapointing. Just garbage.

User Image Skynet2020 Posted - 1 day ago

$BNTX Worst performance in my stock. Just a 1-Hit wonder?

User Image taxplanr Posted - 1 day ago

Does this chart look like what a plandemic with a bioweapon administered as a safe and effective vaccine against the hoax virus would look like? $MRNA $BNTX $PFE https://x.com/stkirsch/status/1782653865969774638

User Image taxplanr Posted - 2 days ago

First call to ban mRNA from clinical trials - “Based on this compelling evidence, we suggest that future clinical trials for cancers or infectious diseases should not use mRNA vaccines with a 100 % m1Ψ (N1-methyl-pseudouridine) modification, but rather ones with the lower percentage of m1Ψ modification to avoid immune suppression.” $BNTX $MRNA $PFE $MRK shareholders should be wary https://x.com/VigilantFox/status/1782198767019553144

User Image taxplanr Posted - 2 days ago

Now, a fascinating interview with a doctor who is among those making a connection between COVID and a mental shift in some people that seem to make them behave like sheep. Nehls: Depression and Alzheimer's have the same cause: a lack of production of new nerve cells in the hippocampus. $MRNA $BNTX $PFE https://fullmeasure.news/newest-videos/the-indoctrinated-brain

User Image taxplanr Posted - 2 days ago

$MRNA $BNTX $PFE walking the mile

User Image Stock_Titan Posted - 2 days ago

$BNTX BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024 https://www.stocktitan.net/news/BNTX/bio-n-tech-to-report-first-quarter-2024-financial-results-and-64pk5nkhye5f.html

User Image SamLamp Posted - 4 days ago

$BNTX A warning is better than a removal, people who have already received several injections should not be terrorized, but should be directed to Novavax as a priority. https://theiowastandard.com/additional-iowa-legislators-candidates-sign-pledge-to-remove-mrna-covid-shots-from-market/

User Image taxplanr Posted - 4 days ago

Doctors consider mRNA a class 1 carcinogen $MRNA $BNTX $PFE https://expose-news.com/2024/04/19/japanese-study-finds-mrna-injections-cause-cancer/

User Image taxplanr Posted - 4 days ago

Surely this can't be happening $PFE $MRNA $BNTX https://expose-news.com/2024/04/19/doctor-says-sorry-for-the-many-mistakes-and-covid-jab-guidance/

User Image countingguy2006 Posted - 5 days ago

$ROIV $ABUS $PFE $BNTX $MRNA We're still waiting for the U.S. government to "chime in" regarding their official position for all of the money they paid to the entities for the covid-19 vaccines! Giving a green light to the infringers crew makes them partially responsible and ABUS didn't attempt to stop the vaccine distribution, but should be compensated normal damages by the government entities (U.S. and others) and treble damages by the infringers as named above!

User Image countingguy2006 Posted - 5 days ago

$ABUS $RIOV $PFE $BNTX $MRNA We're still waiting for the U.S. government to "chime in" regarding their official position for all of the money they paid to the entities for the covid-19 vaccines! Giving a green light to the infringers crew makes them partially responsible and ABUS didn't attempt to stop the vaccine distribution, but should be compensated normal damages by the government entities (U.S. and others) and treble damages by the infringers as named above!

User Image wintogether Posted - 5 days ago

$BNTX I hope they don't go down the drain just like $CVAC did despite them now having the modified mRNA platform. Biontech still has some sales though and has a good cash position, so it's probably a safer investment at this time. Hope these companies solve the bigger problem for humanity, i.e. cancer.

User Image taxplanr Posted - 5 days ago

Could there be a one and done COVID jab to replace $MRNA $BNTX $PFE jabs? As long as adverse reactions are not considered https://childrenshealthdefense.org/defender/small-interfering-rna-covid-flu-vaccine-infants/?utm_source=luminate&utm_medium=email&utm_campaign=defender&utm_id=20240418

User Image taxplanr Posted - 5 days ago

So another jab proponent is all but dead $MRNA $BNTX $PFE https://www.dailymail.co.uk/news/article-13321145/donald-payne-democrat-new-jersey-representative-coma-health-heart-attack.html#:~:text=A%20New%20Jersey%20Democrat%20has,to%20the%20New%20Jersey%20Globe.

User Image taxplanr Posted - 6 days ago

If this meme angers you you maybe long $MRNA $PFE $BNTX

User Image taxplanr Posted - 6 days ago

Did you know $MRNA $PFE $BNTX included nanobot technologies in their modRNA patents? https://www.redvoicemedia.com/video/2024/04/nanobots-that-release-toxins-and-harvest-energy-from-the-body-video/

User Image taxplanr Posted - 1 week ago

Health officials see no need for investigation in the tripling rate of infant mortalities in RI $BNTX $MRNA $PFE https://x.com/stkirsch/status/1780424588251521184

User Image taxplanr Posted - 1 week ago

It seems the bioweapons are working on unborn fetuses also $BNTX $MRNA $PFE https://x.com/McCulloughFund/status/1779895515468972187

User Image BullYa Posted - 1 week ago

$BNTX 📉$80 should be the bottom

User Image taxplanr Posted - 1 week ago

Gain of function research or bioweapon development? $MRNA $BNTX $PFE https://sharylattkisson.com/2024/04/video-exclusive-investigation-separating-rumor-from-fact-on-covid-19s-origin/

User Image erevnon Posted - 1 week ago

HC Wainwright & Co. reiterates BioNTech $BNTX at Buy and maintains a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

User Image taxplanr Posted - 1 week ago

Let's take a trip down memory lane if your brain is still functioning after having taken the gene jab from $BNTX $MRNA $PFE https://expose-news.com/2024/04/16/how-much-damage-have-vaccines-done-to-society/

Analyst Ratings
HC Wainwright & Co. Buy Apr 17, 24
UBS Neutral Mar 27, 24
JP Morgan Underweight Mar 22, 24
BMO Capital Outperform Mar 21, 24
Canaccord Genuity Buy Mar 21, 24
Goldman Sachs Neutral Feb 28, 24
Canaccord Genuity Buy Feb 23, 24
BMO Capital Outperform Feb 23, 24
Canaccord Genuity Buy Feb 21, 24